Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
18.75
-0.27 (-1.39%)
At close: Apr 29, 2026, 4:00 PM EDT
18.72
-0.03 (-0.13%)
After-hours: Apr 29, 2026, 4:01 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
1,5011,021426283368950
Upgrade
Market Cap Growth
478.30%139.48%50.74%-23.21%-61.22%-
Upgrade
Enterprise Value
1,165670228151142583
Upgrade
Last Close Price
19.0115.686.945.657.6120.42
Upgrade
PS Ratio
12.158.265.64---
Upgrade
PB Ratio
5.354.381.911.581.362.73
Upgrade
P/TBV Ratio
6.454.381.911.581.362.73
Upgrade
P/FCF Ratio
--11.22---
Upgrade
P/OCF Ratio
--10.15---
Upgrade
EV/Sales Ratio
9.425.423.01---
Upgrade
EV/FCF Ratio
--6.00---
Upgrade
Debt / Equity Ratio
0.170.170.190.260.17-
Upgrade
Debt / FCF Ratio
--1.12---
Upgrade
Net Debt / Equity Ratio
-1.45-1.45-1.48-1.04-0.79-1.00
Upgrade
Net Debt / EBITDA Ratio
7.377.374.511.361.994.89
Upgrade
Net Debt / FCF Ratio
12.2912.29-8.672.972.055.01
Upgrade
Asset Turnover
0.280.280.20---
Upgrade
Quick Ratio
6.056.052.375.0010.5820.80
Upgrade
Current Ratio
6.126.122.405.0710.7920.96
Upgrade
Return on Equity (ROE)
-16.94%-16.94%-36.15%-60.07%-35.06%-40.35%
Upgrade
Return on Assets (ROA)
-7.64%-7.64%-13.66%-27.72%-19.82%-21.92%
Upgrade
Return on Capital Employed (ROCE)
-14.10%-14.10%-28.80%-55.70%-35.50%-20.80%
Upgrade
Earnings Yield
-2.57%-3.78%-17.05%-47.85%-29.46%-7.79%
Upgrade
FCF Yield
-1.83%-2.69%8.91%-22.22%-28.61%-7.28%
Upgrade
Buyback Yield / Dilution
-12.39%-12.39%-43.80%-8.83%-88.91%-1548.09%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.